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Canonical Wnt and Nodal signaling are both required
for induction of the primitive streak (PS), which
guides organization of the early embryo. The Wnt
effector b-catenin is thought to function in these
early lineage specification decisions via transcrip-
tional activation of Nodal signaling. Here, we demon-
strate a broader role for b-catenin in PS formation by
analyzing its genome-wide binding in a human em-
bryonic stem cell model of PS induction. b-catenin
occupies regulatory regions in numerous PS and
neural crest genes, and direct interactions between
b-catenin and the Nodal effectors SMAD2/SMAD3
are required at these regions for PS gene activation.
Furthermore, OCT4 binding in proximity to these
sites is likewise required for PS induction, suggesting
a collaborative interaction between b-catenin and
OCT4. Induction of neural crest genes by b-catenin
is repressed by SMAD2/SMAD3, ensuring proper
lineage specification. This study provides mecha-
nistic insight into how Wnt signaling controls early
cell lineage decisions.
INTRODUCTION
During gastrulation, induction of the three germ layers is regu-
lated by signaling cues from the emerging primitive streak (PS).
PS formation is spatially initiated at the prospective posterior
end of the mouse embryo and is characterized by regionalized
expression of lineage-specific markers (Tam et al., 2006).
Through an epithelial-mesenchymal transition, epiblast cells
that will give rise to endoderm and mesoderm lineages invagi-
nate through the streak and migrate anteriorly, while cells re-
maining in the epiblast give rise to surface ectoderm and neural
ectoderm (Tam and Behringer, 1997).
Early stages of embryonic development are specified both
temporally and spatially through the coordinated activities ofvarious signaling pathways, including Wnt, Nodal, and BMP
(bone morphogenetic protein). It is well known that the trans-
forming growth factor (TGF)-b family member Nodal promotes
anterior-posterior axis patterning in the gastrulating mouse
embryo; high levels promote anterior fates, whereas a graded
response to lower levels allows regional specification toward
different mesodermal derivatives (Dunn et al., 2004; Kinder
et al., 1999). Wnt3 helpsmaintain high levels of Nodal expression
through direct regulation of the proximal epiblast enhancer in the
Nodal locus (Norris and Robertson, 1999; Vincent et al., 2003).
Nodal mutant embryos in which the proximal epiblast enhancer
element has been deleted lack anterior structures as a result of a
failure in specification of definitive endoderm (DE), which also
works as a signaling modulator for the anterior neuroectoderm
(Norris and Robertson, 1999; Vincent et al., 2003). In addition,
mice deficient in activators of the Wnt signaling pathway, such
as b-catenin, theWnt co-receptors Lrp5/Lrp6, and the processor
of the Wnt molecule Porcupine fail to form PS and mesoderm
(Biechele et al., 2011; Fu et al., 2009; Hsieh et al., 2003; Huelsken
et al., 2000; Kelly et al., 2004; Liu et al., 1999). Re-examination of
an epiblast-specific Wnt3 mutant mouse shows that PS is
induced, but not maintained, in these animals, highlighting the
need of sustained Wnt signaling in the epiblast for gastrulation
(Tortelote et al., 2013). Thus, canonical Wnt and Nodal signaling
are required for PS formation. However, whether b-catenin is
simply required for regulating Nodal expression or targets
several key transcriptional regulators of PS is unclear.
Whereas Wnt and Nodal/TGFb signaling work together in the
regulation of PS formation, they play opposite roles during neural
induction. High levels ofWnt signaling promote the expression of
Gbx2, Pax3, and Tfap2a, which are essential for specification of
posterior neural fates such as neural crest progenitor (NCp) cells
(Kiecker and Niehrs, 2001; Li et al., 2009). In contrast, TGFb
signaling inhibits neural induction (Hemmati-Brivanlou and
Melton, 1994; Surmacz et al., 2012). In fact, dual blockage of
BMP and NODAL signaling has been used to direct differentia-
tion of human embryonic stem cells (hESCs) into neuroectoderm
and neural crest progenitors in vitro (Menendez et al., 2011).
Here, we study how b-catenin regulates differentiation of
hESCs. Initial activation of Wnt signaling induces expression of
direct targets of b-catenin, among them markers of NCp.Cell Stem Cell 16, 639–652, June 4, 2015 ª2015 Elsevier Inc. 639
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b-catenin’s activation also promotes a sustained increase in
NODAL levels and SMAD2/SMAD3 activity, resulting in downre-
gulation of NCp gene expression and induction of PS genes.
Genome-wide analysis of b-catenin binding sites revealed direct
binding of b-catenin to regulatory regions in both PS and NCp
genes. Transcriptional regulation of PS genes requires binding
of b-catenin, OCT4, and SMAD2/SMAD3 to these regulatory
regions; removal of OCT4 or suppression of NODAL signaling
prevents b-catenin-mediated PS induction. Subsequent differ-
entiation into DE is also blocked, while expression of NCp
markers is restored. We also show that it is the SMAD2/
SMAD3 activation levels that determine cell fate choices beyond
the PS state. Our findings provide mechanistic information on
how hESCs coordinate inputs from theWnt and Nodal pathways
to regulate early lineage-specific differentiation.
RESULTS
Canonical Wnt Signaling Regulates NODAL Expression
and PS Specification
To study how activation of Wnt signaling influences PS induction
in hESCs, we used CHIR99021 (CHIR), an inhibitor of glycogen
synthase kinase (GSK-3), for 24 hr (day 1) (Figure 1A). Canonical
Wnt signaling requires the stabilization and activation of b-cate-
nin in order to induce target gene expression. The stability of
b-catenin is regulated through phosphorylation by glycogen syn-
thase kinase 3 (GSK-3). Upon engagement of Wnt signaling,
GSK-3 is inactivated, allowing unphosphorylated b-catenin to
accumulate, translocate to the nucleus, and activate transcrip-
tion by associating with the transcription factor/lymphoid
enhancer-binding factor (TCF/LEF) transcription factors (Aberle
et al., 1997; Novak and Dedhar, 1999). Although GSK-3 pos-
sesses multiple substrates (Forde and Dale, 2007), inhibition
with CHIR has consistently been used as a surrogate for Wnt
signaling to promote b-catenin activation in the context of
hESC differentiation (Kunisada et al., 2012; Naujok et al., 2014;
Pagliuca et al., 2014; Rezania et al., 2014; Tan et al., 2013). We
corroborated these findings by showing that CHIR induced lucif-
erase expression from a reporter containing TCF binding sites
(TOPFlash) as well as expression of the direct b-catenin targets
LEF1 and AXIN2 (Figures 1B–1C).
Interestingly, time-course studies showed that CHIR treatment
induced expression of NODAL, rapidly followed by induction of
its downstream target LEFTY and PS markers BRACHYURY (T),
EOMES, MIXL1, and GOOSECOID (GSC) (Figures 1D–1F, S1A,Figure 1. WNT and NODAL Signaling Regulate PS Formation
(A) Diagram describing the differentiation protocol from hESC to DE.
(B) Cells transducedwith a FopFlash- or TopFlash-luciferase reporter were treated
presented.
(C) Expression of b-catenin targets AXIN2 and LEF1 was analyzed at different tim
(D and E) Cells treated for 24 hr as indicated. Gene expression forNODAL, LEFTY (
normalized to undifferentiated cells (hES).
(F and G) Cells were treated for 24 hr as indicated and immunostained for T (F) a
(H) Cells were treated as indicated, and lysates were analyzed by immunoblot. D
(I) Cells transfected with siRNA pools for b-catenin, SMAD2, or a scrambled con
qPCR. Data were normalized to CHIR-treated scrb-transfected cells.
(J) Cells transfected with siRNA pools for b-catenin or a scrambled control (scrb)
above.
Data in this figure are presented as mean ± SEM of at least three independent expand S1B). To validate the functionality of the CHIR-induced PS,
we followed the conversion of PS into DE by adding ACTIVIN A
(AA) for 2 days after the 24-hr CHIR treatment (Figure 1A). One-
day treatment with AA after CHIR removal was sufficient for effi-
cient induction of DE markers, such as SOX17, FOXA2, CXCR4,
and CERBERUS (CER) (Figure S1F). Approximately 95% of the
cells expressedSOX17 at the end of the CHIR-AA 3-day protocol
(Figure S1C). Notably, the expression levels of SOX17 and
CXCR4 on day 3 were much higher in cells initially treated with
CHIR, compared to high WNT3A or WNT3A+AA (Figures S1D
andS1E), suggesting a relationship between high initial b-catenin
activity and high DE induction. These results were reproduced in
an independent hESC culture system (Figures S2A–S2C). Finally,
as a sign of the authenticity of the putative DE cells, we show that
they are capable of differentiating into multipotent pancreatic
progenitors (75% PDX1+/NKX6.1+ cells; Figure S1G) (Hald
et al., 2008, Jennings et al., 2013).
Binding of NODAL to the ALK4/ALK7 receptors leads to phos-
phorylation, activation, and nuclear translocation of SMAD2/
SMAD3—a prerequisite for transcriptional regulation of its target
genes. As expected, CHIR-mediated increase inNODAL expres-
sion led to increased receptor-mediated phosphorylation as well
as nuclear localization of SMAD2/SMAD3 (Figures 1G and 1H).
Addition of the ALK4/ALK5/ALK7 inhibitor SB431542 (SB)
completely blocked endogenous NODAL signaling as early as
3 hr after treatment as well as CHIR-inducedNODAL expression,
SMAD2/SMAD3activation, andPSgeneexpression (Figures 1D–
1H). It has been reported that GSK-3b regulates SMAD3 protein
stability through phosphorylation-induced proteosomal degra-
dation (Guo et al., 2008). CHIR-induced NODAL signaling may
therefore result from direct modulation of SMAD2 activity rather
than through b-catenin activation. However, we observed no
change in SMAD2protein levels inCHIR-treated cells (Figure 1H).
In support of a direct role of b-catenin downstream of CHIR, we
observed that siRNA-mediated knockdown of the expression of
either b-catenin (siR b-cat) or SMAD2 (siR SMAD2) dramatically
reduced CHIR-induced expression of NODAL, MIXL1, EOMES,
and T (Figure 1I). Neither b-catenin nor SMAD2 knockdown
affected each other’s expression levels, or that of the pluripo-
tencymarkersOCT4, NANOG, andSOX2 (Figure S2E), indicating
that the cells remained pluripotent before CHIR treatment. Since
b-catenin knockdown decreased CHIR-induced SMAD2 nuclear
localization without affecting SMAD2 expression (Figures S2D–
S2F), our data altogether has uncovered an unanticipated indis-
pensable role of b-catenin in the regulation of PS induction.as indicated. Experiments were performed in triplicate, and average values are
e points after CHIR treatment and normalized to undifferentiated cells (hES).
D), T,MIXL1, andEOMES (E) was analyzed at different time points by qPCR and
nd SMAD2 (G). Scale bar, 25 mm.
ata are representative of three independent experiments.
trol (scrb) were treated with CHIR for 24 hr. Gene expression was analyzed by
were treated with RPMI or 100 ng/ml AA for 3 days and analyzed as described
eriments. *p < 0.05, **p < 0.005, and ***p < 0.0005. See also Figures S1 and S2.
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Previous studies in mice and pluripotent stem cells suggest
that themain role of b-catenin in PS induction is to regulate Nodal
expression (Ben-Haim et al., 2006; Dahle et al., 2010; Liu et al.,
1999; Singh et al., 2012). If b-catenin’s role is limited to the induc-
tion of Nodal signaling, then replacing CHIR with AA during the
first 24 hr should induce PS gene expression equally efficiently.
Although expression of the direct AA target LEFTY was readily
induced after 24 hr of AA treatment, we detected only a modest
induction of NODAL, T, EOMES, and MIXL1 expression in com-
parison to CHIR (Figures 1D and 1E). Time-course analysis of AA
treatment showed a more substantial increase in the expression
of the PS markers MIXL1, EOMES, and GSC starting on day 2,
while expression of SOX17 was detected from day 3 (Figure 1J).
Interestingly, expression of siR-b-cat blocked AA-induced ex-
pression of these markers without affecting expression of LEFTY
(Figure 1J), indicating that b-catenin is necessary for AA-induced
differentiation. Wnt/b-catenin signaling also regulates expres-
sion of the NODAL co-receptor CRIPTO (Morkel et al., 2003),
which is essential for transduction of Nodal signaling to
SMAD2/SMAD3 (Gritsman et al., 1999; Yeo and Whitman,
2001). However, induction of CRIPTO expression was not de-
tected in cells treated with CHIR or AA (Figure S2G). These
data further substantiate the idea that b-catenin is required for
PS gene induction, and, essentially, they indicate that b-cate-
nin’s role goes beyond the mere induction of NODAL expression
and signaling. Consistent with this new concept was the effect of
reducing expression of NODAL with siRNAs. Even though siR-
NODAL compromised CHIR-mediated PS and DE induction
(Figure S2H), the response was limited compared to siR-b-cat.
Altogether, our results not only support the previously demon-
strated role of the canonical Wnt pathway as a key regulator of
NODAL activity (Barrow et al., 2007; Brennan et al., 2001; Morkel
et al., 2003) but more importantly highlight an unanticipated cell-
autonomous role of canonical Wnt signaling in the regulation of
PS induction.
b-Catenin Binds Directly to Regulatory Regions in PS
Genes
To obtain a global view of b-catenin’s transcriptional targets dur-
ing early cell fate specification, chromatin immunoprecipitation
followed by high-throughput sequencing (ChIP-seq) was per-
formed in differentiating hESCs. To catch the early changes in
genome occupancy by b-catenin, ChIP-seq was performed
6 hr after treatment with CHIR or CHIR+SB and compared to
mock-treated cells. As expected, CHIR treatment resulted in
an increase in the number of b-catenin’s binding sites compared
to control cells (Figure 2A; Table S1). Global analysis of the new
binding events showed that most of them occurred in upstream
and intergenic regions. Importantly, analysis of the ChIP-seq
data suggests that b-catenin might have a wider impact in regu-
lating PS induction than previously anticipated. Earlier studies
have implicated b-catenin in the regulation of Nodal and T
expression through direct binding to their regulatory regions (Ar-
nold et al., 2000; Ben-Haim et al., 2006; Yamaguchi et al., 1999).
Here, we confirm these results in hESCs and show that b-catenin
binds to upstream regulatory regions in most previously identi-
fied PS genes, including NODAL, T, EOMES, MIXL1, GSC,
WNT3, EVX1, and GATA4 (Table S1). Notably, b-catenin binding
in PS gene proximal regions is maintained in cells treated with642 Cell Stem Cell 16, 639–652, June 4, 2015 ª2015 Elsevier Inc.CHIR+SB (Figure 2B; Table S1), and Gene Ontology analysis
revealed that both CHIR and CHIR+SB induced binding of b-cat-
enin in the proximity of a common set of genes involved in
biological processes such as pattern specification, mesoderm
development, and gastrulation (Figure 2C; Table S2).
To validate binding of b-catenin to NODAL, EOMES, and
MIXL1, ChIP-qPCR analysis was carried out. Specifically, anal-
ysis of selected regulatory regions, as determined in our ChIP-
seq (from transcription start site [TSS]:NODAL,13 kb; EOMES,
6 kb; and MIXL1, 13 kb), demonstrated binding of b-catenin
to all three regions upon 19 hr treatment with CHIR (Figure 2D).
In confirmation of the results obtained in the ChIP-seq, b-catenin
binding was maintained in cells treated for 19 hr with CHIR+SB
(Figure 2D). As NODAL signaling and SMAD2/SMAD3 activity
are completely abrogated under these conditions, the data indi-
cate that the binding of b-catenin occurs directly in response to
CHIR treatment and is independent of NODAL/SMAD2/SMAD3
signaling.
b-Catenin and SMAD2/SMAD3 Bind to the Same
Regulatory Regions in PS Genes
Based on the observations that b-catenin-mediated induction of
PS gene expression depends on binding of b-catenin to PS
genes and on SMAD2/SMAD3 activity, we hypothesized that
b-catenin, in addition to increasing SMAD2/SMAD3 activation
through NODAL expression, more directly collaborates with
SMAD2/SMAD3 at the chromatin level to regulate PS gene acti-
vation. Indeed, analysis of SMAD2/SMAD3 occupancy at the
regulatory regions bound by b-catenin showed a CHIR-depen-
dent induction in the binding of SMAD2/SMAD3 to these sites
(Figure 3A). As expected, binding was reduced in cells treated
with CHIR+SB. Interestingly, binding of SMAD2/SMAD3 to the
b-catenin binding regions in NODAL, EOMES, and MIXL1 in un-
differentiated hESCs was previously demonstrated by SMAD2/
SMAD3 ChIP-seq (Kim et al., 2011). It was also shown that
SMAD2/SMAD3 is recruited to different SMAD binding elements
(SBEs) upon AA-induced differentiation. We analyzed whether
CHIR-induced NODAL signaling promoted binding of SMAD2/
SMAD3 to the reported AA-responsive SBEs in NODAL,
MIXL1, and GSC (from TSS: NODAL, +0.9 kb; MIXL1, TSS;
GSC, 5.5 kb) (Kim et al., 2011). Indeed, we show that CHIR
treatment induced SMAD2/SMAD3 binding to these SBEs and
that addition of SB blocked these binding events (Figure 3B).
Importantly, knocking down b-catenin expression dramatically
reduced CHIR-induced binding of SMAD2/SMAD3 to both the
b-catenin- and SMAD-binding elements (Figures 3A and 3B).
Co-immunoprecipitation analysis showed that b-catenin and
SMAD2/SMAD3 form a complex, which is further stimulated
upon CHIR treatment (Figure 3C). To determine whether this
interaction translates into a simultaneous occupancy of binding
sites, ChIP for b-catenin was performed followed by re-ChIP
for SMAD2/SMAD3. Indeed, we detected co-occupancy of
b-catenin and SMAD2/SMAD3 at the b-catenin binding region
onMIXL1 upon CHIR treatment (Figure 3D). As expected, in cells
treated with CHIR+SB the co-occupancy is lost because
SMAD2/SMAD3 binding is prevented. These results support a
new concept for how b-catenin controls PS initiation: the forma-
tion of a complex with SMAD2/SMAD3, and the binding of this
complex to specific regulatory regions on PS genes allows
Figure 2. b-Catenin Binds Directly to Regulatory Regions in the PS Genes
Cells treated with CHIR or CHIR+SB or mock treated (RPMI) for 6 hr were subjected to ChIP-seq analysis for b-catenin.
(A) Genomic distribution of binding sites as a percentage of the total peaks obtained in each condition.
(B) University of California, Santa Cruz (UCSC) tracks were generated for EOMES, MIXL1, and NODAL from the b-catenin ChIP-seq.
(C) Gene Ontology analysis for processes in which b-catenin-bound genes are enriched in cells treated with CHIR and CHIR+SB.
(D) Cells treated as indicated for 19 hr were subjected to ChIP with a b-catenin and isotype IgG control antibody. Enrichment at the indicated b-catenin
binding sites inNODAL, EOMES, andMIXL1was analyzed by qPCRand normalized to input. Data are presented as fold enrichment relative to an unbound control
region.
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Figure 3. b-Catenin-Driven Expression of PS Genes Is Dependent on SMAD2/SMAD3
(A and B) Cells treated as indicated for 19 hr were subjected to ChIP with a SMAD2/SMAD3 and isotype IgG control antibody. Cells transfected with siRNA pools
for b-catenin were treated with CHIR 48 hr after transfection and processed as the rest. Enrichment at the indicated b-catenin binding sites in NODAL, EOMES,
andMIXL1 (A) and at the indicated SBE sites (B) was analyzed by qPCR and normalized to input. Data are presented as fold enrichment relative to an unbound
control region.
(C) Cells were treated as indicated. Cellular lysates were immunoprecipitated with a SMAD2 or IgG control antibody. The presence of b-catenin, pSMAD2, and
total SMAD2 in the precipitates was analyzed by western blot. Input levels are shown as controls on the right side. The data are representative of three inde-
pendent experiments.
(D) Cells were treated for 19 hr as indicated. b-catenin ChIP was performed followed by ChIP with SMAD2/SMAD3 or isotype IgG control antibody. Enrichment at
the MIXL1 13 kb locus was determined by qPCR and normalized to input. Data are presented as fold enrichment relative to an unbound control region.
Data in this figure are presented as mean ± SEM of at least three independent experiments. *p < 0.05, **p < 0.005, and ***p < 0.0005.b-catenin to reinforce NODAL expression and promote PS
commitment.
b-Catenin Promotes Expression of Neural Crest
Progenitor Genes in the Absence of SMAD2/SMAD3
Activation
The Gene Ontology analysis of the ChIP-seq data also revealed
binding of b-catenin to genes involved in neural development
and neural crest cell differentiation and that these binding events
were enriched in response to blockage of SMAD2/SMAD3
signaling (CHIR+SB; Figure 2C). This finding is in line with previ-
ous observations that CHIR+SB treatment induces differentia-
tion of hESCs toward neural crest cell fates (Chng et al., 2010;644 Cell Stem Cell 16, 639–652, June 4, 2015 ª2015 Elsevier Inc.Menendez et al., 2011; Patani et al., 2009). Our ChIP-seq data
showedCHIR-induced binding of b-catenin to regulatory regions
in GBX2, TFAP2A, MSX1, and PAX3, which are expressed in
cells at the border between neural and nonneural ectoderm as
well as in early NCp (Figure 4A; Table S1) (Li et al., 2009; Mon-
soro-Burq et al., 2005; Plouhinec et al., 2014). In fact, it has
been well documented that Wnt signaling plays a critical role in
neural crest induction (reviewed in Bae and Saint-Jeannet,
2014). Consistent with this observationwe found that CHIR treat-
ment induced early expression (3 hr) of TFAP2A, MSX1, GBX2,
ZIC1, and PAX3. However, the expression of these genes dimin-
ished with time (Figure 4B). The decline in expression of these
NCp genes coincided with the induction of PS gene expression,
Figure 4. Suppression of NODAL Signaling Allows WNT-Induced NCp Fate
(A) UCSC tracks were generated for GBX2, TFAP2A, and MSX1 from the b-catenin ChIP-seq.
(B) Cells were treated as indicated, and gene expression was analyzed at different time points by qPCR. Data were normalized to undifferentiated cells (hES).
(C and D) Cells transfected with siRNA pools for b-catenin, SMAD2, NODAL, or a scrambled control (scrb) were treated with CHIR for 24 hr. Gene expression was
analyzed by qPCR. Data were normalized to CHIR-treated scrb-transfected cells.
(E) Cells were treated as indicated. Gene expression was analyzed at different time points by qPCR. Data were normalized to undifferentiated cells (hES).
(F) Cells were treated as indicated for 24 hr and immunostained for T and TFAP2A. Scale bar, 50 mm.suggesting that b-catenin-induced Nodal/SMAD2/SMAD3 sig-
naling may block neural crest specification. Indeed, while NCp
gene expression declined upon reduction in b-catenin expres-
sion levels (Figure 4C, see inset for TFAP2A), knocking down
expression of SMAD2 or NODAL promoted NCp gene expres-
sion in response to CHIR treatment (Figures 4C and 4D). Similar
results were obtained by pharmacological blockage of SMAD2/
SMAD3 activation (CHIR+SB) (Figures 4E and 4F). The fact that
blockage of SMAD2/SMAD3 activity results in increased expres-
sion of NCp genes only at the timewhen Nodal signaling is active(18 to 24 hr after CHIR treatment) (Figure 1E) underscores the
importance of b-catenin-mediated induction of Nodal signaling
as a key inhibitory signal for NCp induction.
OCT4 Co-Occupies b-Catenin Binding Regions to
Regulate PS Gene Expression
Although b-catenin-induced transcription is mainly mediated
through its interaction with the TCF/LEF proteins, there are re-
ports suggesting that b-catenin associates with a variety of
different transcription factors (reviewed in Valenta et al., 2012).Cell Stem Cell 16, 639–652, June 4, 2015 ª2015 Elsevier Inc. 645
Figure 5. OCT4 Promotes PS Gene Induction
(A) Putative TCF/LEF and OCT4 binding sequences identified by motif enrichment analysis in the b-catenin peaks.
(B) Histograms showing the distribution of distances from each b-catenin peak (left histogram) or randomized control region (right histogram) to the nearest peak
in previously published OCT4 ChIP-seq data (GSM539547).
(C) Cells were treated with CHIR for 19 hr and subjected to ChIP with anOCT4 or isotype IgG control antibody. Enrichment at the indicated b-catenin binding sites
in NODAL, EOMES, and MIXL1 was analyzed by qPCR and normalized to input. Data are presented as fold enrichment relative to an unbound control region.
(D) Cells were treated for 19 hr as indicated. b-catenin ChIP was performed followed by ChIP with OCT4 or isotype IgG control antibody. Enrichment at the
indicated loci was determined by qPCR and normalized to input. Data are presented as fold enrichment relative to an unbound control region.
(E) Cells were transfectedwith siRNA pools for OCT4 or a scrambled control (scrb). Twelve hours after transfection, cells were treatedwith RPMI or CHIR for 24 hr,
and lysates were analyzed by immunoblot.
(F) Cells were transfected as in (E) and treated for 24 hr as indicated. Expression of markers for PS was analyzed by qPCR and normalized to scrb-transfected
control cells.
Data in this figure are presented as mean ± SEM of at least three independent experiments. *p < 0.05, **p < 0.005, and ***p < 0.0005.To identify b-catenin’s binding partners during transcriptional
regulation of PS genes, we performed de novo binding motif
analysis on the b-catenin ChIP-seq peaks. We found that similar
motifs were enriched under both CHIR andCHIR+SB conditions,
including a putative TCF/LEF motif (Figure 5A). Surprisingly, a
motif resembling a previously described OCT4 binding motif
(Mullen et al., 2011) was also enriched in both conditions (Fig-
ure 5A), suggesting that b-catenin and OCT4 may transcription-
ally coordinate early developmental programs in hESCs. A direct
interaction between b-catenin and OCT4 has previously been re-
ported in mouse embryonic stem cells (mESCs) under pluripo-
tency conditions (Faunes et al., 2013; Kelly et al., 2011; Takao
et al., 2007). Although this interaction promotes OCT4 transcrip-
tional activity, it occurs in a TCF/LEF-independent manner and
does not require b-catenin’s transcriptional activity (Faunes
et al., 2013; Kelly et al., 2011). Binding of OCT4 to a TCF/LEF-
OCT4 composite site has been shown to regulateMesp1 expres-
sion during differentiation of mESCs (Li et al., 2013). A role for646 Cell Stem Cell 16, 639–652, June 4, 2015 ª2015 Elsevier Inc.OCT4 in PS induction has also been documented (DeVeale
et al., 2013; Thomson et al., 2011; Trott and Martinez Arias,
2013; Wang et al., 2012); however, the mechanism by which
OCT4 regulates PS gene expression is still not fully understood.
To elucidate whether b-catenin and OCT4 could co-regulate
early hESC differentiation, we compared their genome-wide oc-
cupancy during early lineage specification. Because no ChIP-
seq data are available for OCT4 in differentiating hESCs, we
compared the b-catenin ChIP-seq data from CHIR-treated
hESCs (6 hr) with OCT4 ChIP-seq data obtained from undifferen-
tiated hESCs (Mullen et al., 2011). We found that for 35.9%of the
b-catenin peaks (378 out of 1,053), an OCT4 binding region was
located within a distance of 1 kb of the b-catenin binding site
(Figure 5B). To test that this was not an indirect consequence
of both factors randomly occurring in the proximity of genes,
we generated a set of randomized control regions that on a pop-
ulation level matched the b-catenin peaks in respect to TSS dis-
tance and orientation. The vast majority of these control regions
were found at distances greater than 10 kb from OCT4 binding
regions, suggesting that the colocalization of a large part of the
b-catenin peaks to OCT4 binding regions was unlikely to occur
by chance (Figure 5B). Similar observations have been made
for SMAD3 and OCT4 in undifferentiated hESCs where SMAD3
and OCT4 co-occupy sites throughout the genome (Mullen
et al., 2011).
Interestingly, there was considerable overlap in the peaks ob-
tained in the b-catenin and OCT4 ChIP-seq for the PS markers
EOMES, NODAL, MIXL1, WNT3, and EVX1 (Table S3). These
data suggest that coordinated binding of b-catenin and OCT4
might regulate expression of PS genes during CHIR-induced dif-
ferentiation. In fact, ChIP-qPCR experiments demonstrated that
in cells treated with CHIR, OCT4 binds to the b-catenin regulato-
ry regions in EOMES,NODAL, andMIXL1 (Figure 5C). Sequential
ChIP (ChIP for b-catenin followed by re-ChIP for OCT4) showed
that b-catenin and OCT4 co-occupy the b-catenin binding re-
gions in NODAL and MIXL1 upon CHIR stimulation (Figure 5D).
Interestingly, in cells treated with CHIR+SB the chromatin co-oc-
cupancy of OCT4 and b-catenin was reduced, suggesting that
efficient binding of these factors to genomic sites might be
dependent on the presence of activated SMAD2/SMAD3. The
observation that PS induction requires cooperative binding of
b-catenin, OCT4, and SMAD2/SMAD3 to regulatory regions in
PS genes identifies for the first time a functional link between
these factors in PS induction.
To functionally test the role of OCT4 in b-catenin-driven early
differentiation, OCT4 expression was reduced by expressing
OCT4 siRNAs (siR OCT4) (Figures 5E and 5F). Previous work
demonstrated that reduced expression of OCT4 in hESCs results
in induction of trophectoderm (TE) markers through BMP4 acti-
vation (Wang et al., 2012; Zafarana et al., 2009). However,
upon a short 12 hr transfection with OCT4 siRNAs, OCT4
mRNA and protein levels were significantly downregulated,
without affecting the levels of NANOG and SOX2 (Figure 5E).
No expression of the TE marker HAND1 could be detected (Fig-
ure 5E), suggesting that the cells remained in a pluripotent state.
Reduced expression of OCT4 dramatically inhibited CHIR-
induced NODAL and PS gene expression (Figure 5F), consistent
with the requirement of a b-catenin/OCT4/SMAD2/SMAD3
complex to promote PS gene expression. Our findings highlight
the existence of multiple collaborative interactions between
b-catenin and OCT4, which ultimately determine the outcome
of b-catenin-mediated transcriptional regulation of early cell
fate specification.
Fate Determination beyond the PS State Is Regulated by
NODAL Levels
On the basis of studies in vivo (embryo) and in vitro (ESCs), the
current model for how the PS transitions into DE involves
increased SMAD2/SMAD3 activation (Robertson, 2014; Trem-
blay et al., 2000). To mimic this step in vitro, most protocols de-
signed to induce PS and DE from pluripotent stem cells use very
high concentrations of AA (50–100 ng/ml). Our results indicate
that activation of b-catenin is sufficient to induce PS via
increased NODAL production leading to increased SMAD2/
SMAD3 activation. This raises the interesting question whether
the endogenously produced NODAL is sufficient to differentiate
PS progenitors into DE. To test this idea, hESCs were treatedwith CHIR for 24 hr and then by varying concentrations of AA
on days 2 and 3, ranging from no AA to low AA (10 ng/ml) and
high AA (50–100 ng/ml). To our surprise, induction of SOX17
expression was observed in cells exposed to no, low, and high
AA. As expected, SB addition significantly reduced induction
of SOX17 (Figures 6A–6D). Remarkably, SOX17 expression
was maintained even after 2 days without AA supplementation.
However, these SOX17+ cells were mainly detected in clusters
in contrast to the homogeneous expression pattern observed
under high-AA exposure (Figure 6D). Similarly, CXCR4 and
CER were equally induced by low and high doses of AA
(Figure 6A); however, expression was significantly lower in the
absence of exogenous AA. Interestingly, these conditions
promoted expression of endothelial markers, such as CD31
(PECAM-1), VE-cad, and RUNX1 (Figure S3A), consistent with
previous reports demonstrating expression of Sox17 in vascular
progenitors in the mouse (Choi et al., 2012; Engert et al., 2013).
However, markers characteristic for cardiac mesoderm, ecto-
derm, or primitive endoderm were not significantly upregulated
under any of these conditions (Figures S3B, S3D, and S3E).
These results indicate that although endogenous NODAL is suf-
ficient for differentiation of the PS, increased SMAD2/SMAD3
activation (sufficient with 10 ng/ml of AA) is necessary for effi-
cient differentiation of PS into DE.
Although blocking SMAD2/SMAD3 signaling (SB) during days
2 and 3 totally abrogated expression of DE markers, it signifi-
cantly increased expression of T and NCp genes (Figures 6B,
6C, and 6E). The facts that EOMES or MIXL1 expression is
reduced and TBX6 expression is increased (Figures 6B and
S4C) suggest that the T-expressing cells most likely represent
the transition from PS into a mesodermal fate such as paraxial
mesoderm (Tan et al., 2013). In agreement with previous data
(Menendez et al., 2011), prolonged blockage of SMAD2/
SMAD3 signaling leads to expression of additional NCpmarkers,
including SOX9 and SLUG (in addition to TFAP2A, MSX1, and
PAX3) (Figure 6C).
Altogether, our data show that b-catenin-induced endoge-
nous NODAL signaling is sufficient for its contribution to PS
induction but that conversion of PS into DE requires higher con-
centrations of NODAL. Furthermore, blocking endogenous
SMAD2/SMAD3 activation redirects PS into mesodermal and
neural crest fates.
DISCUSSION
To recapitulate the early steps in canonical Wnt-induced cell
lineage specification in hESCs, we have taken as a reference
point studies performed in vivo where Wnt and Nodal/TGFb/
BMP cross-regulatory signaling has been described. The results
presented here offer new insights into the role of b-catenin in
early lineage commitment. Our b-catenin ChIP-seq study is
unique in that it provides for the first time a genome-wide view
of the extent of b-catenin involvement in early hESC differentia-
tion, revealing a direct regulation of both PS and NCp genes. Our
study shows that b-catenin’s role in PS induction is not merely to
activate SMAD2/SMAD3 through regulation of NODAL expres-
sion; efficient PS induction relies on the formation of a physical
complex with SMAD2/SMAD3 and binding in proximity to
OCT4 on chromatin at promoter proximal regions of PS genes.Cell Stem Cell 16, 639–652, June 4, 2015 ª2015 Elsevier Inc. 647
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Figure 7. Mechanism for the Regulation of
Wnt-Induced Early Lineage Choices
Under pluripotency conditions, OCT4 and SMAD2
co-occupy upstream regulatory regions on PS
genes. CHIR treatment promotes stabilization
b-catenin, which is recruited to regulatory regions
in PS and NCp genes. Initially, activation of Wnt
signaling induces expression of NCp. Binding of
b-catenin, SMAD2/SMAD3, and OCT4 to chro-
matin promotes a sustained increase in NODAL
levels and SMAD2/SMAD3 activity, resulting in
downregulation of NCp gene expression and in-
duction of PS genes. See text for more details.Our data indicate that b-catenin-mediated enhancement of
NODAL signaling promotes expression of PS genes while block-
ing expression of NCp genes (Figure 7).
We show for the first time that b-catenin binds to regulatory
regions in a majority of PS gene loci. However, binding of
b-catenin alone is not sufficient to initiate transcription and re-
quires that a complex with SMAD2/SMAD3 is formed and binds
together with OCT4 on chromatin. This mode of action prob-
ably explains the delay in PS gene induction observed when
only exogenously added AA is used to initiate differentiation.
Most likely, a gradual accumulation of Wnt ligands in response
to prolonged AA treatment leads to the required binding of
b-catenin and activated SMAD2/SMAD3 to the regulatory re-
gions in PS genes.
b-catenin also binds to regulatory regions in NCp genes, but
expression of these genes can be sustained only if NODAL
signaling is inhibited. The precise mechanism by which this oc-
curs is not completely clear. We failed to detect binding of
SMAD2/SMAD3 to the b-catenin regulatory regions of TFAP2A
and MSX1 in response to CHIR (data not shown), suggesting
that direct binding of SMAD2/SMAD3 to these regions is unlikely
to mediate regulation of their expression. Furthermore, a screen
through reported genome-wide SMAD3 binding regions in undif-
ferentiated hESCs showed that SMAD3 is absent from the
regulatory regions on TFAP2A and GBX2 (Mullen et al., 2011).
Similarly, SMAD2 ChIP-seq datasets from undifferentiated cells
also report lack of SMAD2 binding to the b-catenin sites inGBX2,
MSX1 (Brown et al., 2011; Kim et al., 2011), and TFAP2A (Brown
et al., 2011). Thus, it seems unlikely that SMAD2/SMAD3 re-
presses NCp induction through directly binding to NCp genes.
Interestingly, NANOG knockdown increases expression of
GBX2 and PAX3 in hESCs (Wang et al., 2012). Since NANOG
expression is regulated by SMAD2/SMAD3 activity (Vallier
et al., 2009; Xu et al., 2008), the boost in NCp gene expression
detected upon CHIR+SB treatment might reflect the combined
actions of a direct inducer (b-catenin) and the removal of a nega-
tive regulator (NANOG).
In summary, we show that b-catenin regulates NCp gene
expression through multiple mechanisms. First, b-catenin
directly induces NCp expression. Second, b-catenin indirectlyFigure 6. Graded NODAL Signaling Modulates Fate of PS-like Cells
(A–C) Cells were treated with CHIR for 24 hr, followed by various concentrations o
DE (A), PS (B), and NCp (C) was analyzed by qPCR and normalized to D1 CHIR-
(D and E) Cells were treated as indicated and co-immunostained for T/SOX17 (D
Data in this figure are presented as mean ± SEM of at least three independent erepresses NCp expression through its induction of SMAD2/
SMAD3 activity via NODAL expression.
We also demonstrate that the concentration of exogenously
added AA determines whether the CHIR-induced PS popula-
tion will differentiate into DE (SOX17+), paraxial mesoderm
(T+), or neural crest (TFAP2A+). The potential of PS cells to
differentiate into multiple lineages may be explained by the ex-
istence of various lineage-specific progenitors or multipotent
progenitors. In support of the former, we noted that CHIR treat-
ment resulted in variable levels of T expression (Figure 1G),
which is consistent with in vivo studies showing variable T pro-
tein levels in individual PS cells of wild-type E7.5 embryos.
Whereas cells with lower T levels tend to differentiate into neu-
ral tissue, those expressing high levels exit rapidly from the
streak to form mesoderm (Wilson and Beddington, 1997).
These results are also consistent with recent studies in epiblast
stem cells (EpiSCs) and mESCs, showing that Wnt signaling in-
duces differentiation of a heterogeneous population of T+ PS
cells with different potential to contribute to endoderm or neu-
romesoderm lineages (Tsakiridis et al., 2014). Along the same
lines, a recent report suggests that human PS progenitors
possess distinct identities that restrict their potential to differ-
entiate into mesodermal derivatives (Mendjan et al., 2014).
Alternatively, CHIR treatment may induce differentiation of mul-
tipotent progenitors. In support of this option, clonal analysis in
the mouse embryo demonstrated that although endoderm and
surface ectoderm segregate during gastrulation, neural and
mesodermal lineages share a common bipotent progenitor
(Tzouanacou et al., 2009). Although our data are consistent
with the idea that CHIR treatment generates PS-like cells that
retain a certain degree of plasticity toward different lineages,
future studies will have to elucidate the existence of lineage-
specific or bipotent progenitors for human PS and neural crest
lineages.EXPERIMENTAL PROCEDURES
Cell Culture and Differentiation
SA121 hESCs were grown in DEF-CS media (Takara). When indicated, cells
were cultured in Matrigel (BD Biosciences) with mTeSR1 media (Cell Signalingf AA or SB for an additional 48 hr as indicated. Gene expression for markers of
treated cells.
) and T/TFAP2A (E). Scale bars, 100 mm (left) and 50 mm (right).
xperiments.**p < 0.005 and ***p < 0.0005. See also Figure S3.
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Technologies). hESC cultures were treated with 3 mM CHIR99021 (Stemgent)
in RPMI-1640. Control cells were left untreated or treated with 100 ng/ml Acti-
vin A (Peprotech) and/or 200 ng/ml Wnt3a (R&D Systems), unless otherwise
indicated. After 24 hr, cells were treated with 100 ng/ml AA in RPMI for
24 hr, followed by AA+2%B27 for 1 to 2 days. When applicable, 10 mM
SB431542 (Sigma) was added. PE differentiation was performed as previously
described (Rezania et al., 2011). For AA-induced differentiation, cells were
treated with 100 ng/ml AA in RPMI+2%B27 for 3 days.
RNA Extraction and qRT-PCR
Total RNA was extracted with the RNeasy Plus Mini kit (QIAGEN) and reverse-
transcribed using the SuperScript III First-Strand synthesis kit (Invitrogen). The
TGFb signaling qPCR array was from SA Biosciences. qRT-PCR experiments
were performed using the StepOnePlus system (Applied Biosystems) and
SYBR-GreenMasterMix (Invitrogen). Primers utilized in this study are available
in the Supplemental Information.
siRNA Silencing
hESCs were transfected with siRNA-pools (SMAD2 and b-catenin, ON-
TARGET plus SMARTpool, Dharmacon; NODAL, Dharmacon/Ambion; and
OCT4, Ambion) or scrambled siRNA control (Ambion) using Lipofectamine
RNAiMAX (Invitrogen) in complete media. Final concentration was 25–
50 nM. Cells were treated 48 hr after transfection. With siR-OCT4, experiments
were initiated 12 hr after transfection.
ChIP Sequencing and Data Processing
ChIP was performed as described previously (Dietrich et al., 2012) with slight
modifications. Antibodies used were b-catenin (R&D Systems, AF1329) and
Goat IgG (ab37373, Abcam). DNA from three parallel ChIPs was pooled, and
10 ng was used for making ChIP-seq libraries. All peak finding, colocalization,
and annotation were done in the program EaSeq (M.L. and K.H., unpublished
data). ChIP-seq data are available in the GEO database under the accession
number GEO: GSE58476. Additional information can be found in the Supple-
mental Experimental Procedures.
ACCESSION NUMBERS
The NCBI GEO accession number for the ChIP-seq data reported in this paper
is GEO: GSE58476.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2015.03.008.
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